| 1 |
27484436 | Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03. | 2017 Jul |
1 |
| 2 |
23846118 | Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis. | 2014 May |
3 |
| 3 |
23376077 | Risedronate increases osteoblastic differentiation and function through connexin43. | 2013 Mar 1 |
2 |
| 4 |
24001743 | Traditional and novel bone remodeling markers in premenopausal and postmenopausal women. | 2013 Nov |
1 |
| 5 |
21627558 | The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | 2011 Dec |
1 |
| 6 |
21659972 | Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | 2011 Jun |
1 |
| 7 |
20190467 | Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study. | 2010 |
1 |
| 8 |
18609099 | Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy. | 2008 |
1 |
| 9 |
15780963 | The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study. | 2005 Feb |
1 |